Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Mirati Therapeutics

    World Rank (Jan-05-2024)
    3,416
    Market Cap (Jan-05-2024)
    4.133 Billion USD
    World Rank (Jul-30-2023)
    6,294
    Market Cap (Jul-30-2023)
    1.725 Billion USD
    World Rank (Dec-25-2022)
    4,725
    Market Cap (Dec-25-2022)
    2.453 Billion USD
    World Rank (Jan-07-2022)
    2,422
    Market Cap (Jan-07-2022)
    7.33 Billion USD
    Annual Revenue in USD
    12 Million USD
    Annual Operating Income in USD
    -759 Million USD
    Annual Net Income in USD
    -740 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Mirati Therapeutics is a Bio Technology and Clinical Collaboration company. The headquarters is in USA.

    Company Website
    MIRATI THERAPEUTICS INC

  2. Amicus Therapeutics

    World Rank (Jan-05-2024)
    3,532
    Market Cap (Jan-05-2024)
    3.968 Billion USD
    World Rank (Jul-30-2023)
    3,630
    Market Cap (Jul-30-2023)
    3.862 Billion USD
    World Rank (Dec-25-2022)
    3,839
    Market Cap (Dec-25-2022)
    3.279 Billion USD
    World Rank (Jan-07-2022)
    4,637
    Market Cap (Jan-07-2022)
    3.18 Billion USD
    Annual Revenue in USD
    329 Million USD
    Annual Operating Income in USD
    -204 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Amicus Therapeutics is a Biotechnology company. The headquarters is in USA.

    Company Website
    AMICUS THERAPEUTICS INC
    Wikipedia
    Wikipedia

  3. Ultragenyx Pharmaceutical

    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    363 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -707 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

    Company Website
    ULTRAGENYX PHARMACEUTICAL INC

  4. Axsome Therapeutics

    World Rank (Jan-05-2024)
    3,584
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    3,778
    Market Cap (Jul-30-2023)
    3.664 Billion USD
    World Rank (Dec-25-2022)
    3,898
    Market Cap (Dec-25-2022)
    3.204 Billion USD
    World Rank (Jan-07-2022)
    8,340
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    50 Million USD
    Annual Operating Income in USD
    -176 Million USD
    Annual Net Income in USD
    -187 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Axsome Therapeutics is a biopharmaceutical company. The headquarters is in USA.

    Company Website
    AXSOME THERAPEUTICS

  5. Organon & Co.

    World Rank (Jan-05-2024)
    3,693
    Market Cap (Jan-05-2024)
    3.740 Billion USD
    World Rank (Jul-30-2023)
    2,666
    Market Cap (Jul-30-2023)
    5.649 Billion USD
    World Rank (Dec-25-2022)
    2,026
    Market Cap (Dec-25-2022)
    7.098 Billion USD
    World Rank (Jan-07-2022)
    2,198
    Market Cap (Jan-07-2022)
    8.20 Billion USD
    Annual Revenue in USD
    6,174 Million USD
    Annual Net Income in USD
    917 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile

    Organon & Co is a Global Healthcare company with a mission to deliver impactful medicines and solutions. It is having more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. The headquarters is in USA.

    Company Website
    Organon & Co.

  6. Arrowhead Pharmaceuticals

    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    243 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -172 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

    Company Website
    ARROWHEAD PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  7. Xenon Pharmaceuticals

    World Rank (Jan-05-2024)
    3,922
    Market Cap (Jan-05-2024)
    3.464 Billion USD
    World Rank (Jul-30-2023)
    5,199
    Market Cap (Jul-30-2023)
    2.331 Billion USD
    World Rank (Dec-25-2022)
    4,829
    Market Cap (Dec-25-2022)
    2.382 Billion USD
    World Rank (Jan-07-2022)
    7,271
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -28 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Canada
    Yahoo @ Nasdaq
    Company Profile
    Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The headquarters is in Canada.
    Company Website
    XENON PHARMACEUTICALS

  8. MoonLake Immunotherapeutics

    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Switzerland
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
    Company Website
    MOONLAKE IMMUNOTHERAPEUTICS

  9. Biohaven Pharmaceutical Holding Company

    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -567 Million USD
    Annual Net Income in USD
    -570 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

    Company Website
    BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

  10. Amphastar Pharmaceuticals

    World Rank (Jan-05-2024)
    4,332
    Market Cap (Jan-05-2024)
    3.040 Billion USD
    World Rank (Jul-30-2023)
    4,422
    Market Cap (Jul-30-2023)
    2.937 Billion USD
    World Rank (Dec-25-2022)
    6,890
    Market Cap (Dec-25-2022)
    1.386 Billion USD
    World Rank (Jan-07-2022)
    8,516
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    498 Million USD
    Annual Operating Income in USD
    107 Million USD
    Annual Net Income in USD
    91 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Amphastar Pharmaceuticals is a Specialty Pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. It produce over 20 commercial products while continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. The headquarters is in USA.
    Company Website
    Amphastar Pharmaceuticals

Share